News | June 25, 2025
Glenmark Pharmaceuticals launches TEVIMBRA in India
TEVIMBRA is a uniquely designed anti-PD-1 monoclonal antibody developed by BeiGene (now BeOne Medicines)
TEVIMBRA is a uniquely designed anti-PD-1 monoclonal antibody developed by BeiGene (now BeOne Medicines)
Bonthapally facility is one of the world's largest single-site Paracetamol API manufacturing plants by volume
The transaction is expected to close in Q2 FY 2026
The company will provide the necessary response to USFDA within stipulated 15 days
Sun Pharma gets 8 observations from USFDA for Halol facility
Conceptulised by Lowe Lintas, the new campaign creatively brings the "fast action" benefit of Cipladine to life through a series of films
Zydus receives EIR for the API manufacturing facility at Ankleshwar
Globally, BRUKINSA is approved in more than 70 countries
Sun Pharma discontinues work on its experimental skin drug SCD-044 after Phase 2 trial results fall short of goals for treating psoriasis and atopic dermatitis
The approval is for the generic version of Victoza, indicated for the treatment of insufficiently controlled Type 2 Diabetes Mellitus
Subscribe To Our Newsletter & Stay Updated
